12/9/2020 7:35:28 AM
Sinovac Announces China NMPA Approves Product License For 23-Valent Pneumococcal Polysaccharide Vaccine
12/7/2020 7:33:48 AM
Sinovac Q3 EPS $0.10 Vs $0.06 Last Year
9/28/2020 8:36:43 AM
Beijing Court Issues Judgement Against Sinobioway And Aihua Pan Liable For Torts And Breaches Of Shareholder Duty
9/22/2020 8:03:14 AM
Sinovac Biotech Recently Commences Phase III Clinical Trials For Its Inactivated COVID-19 Vaccine Candidate In Turkey
8/28/2020 4:37:25 PM
Sinovac Biotech Q2 Loss/share $0.05 Vs. Profit $0.11 Year Ago
8/25/2020 8:34:19 AM
Sinovac Biotech Signs Two Agreements In Hainan, China With PT
Bio Farma
7/6/2020 9:04:05 AM
Sinovac COVID-19 Vaccine Collaboration With Butantan Gets Approval From Brazilian Regulator For Phase III Trial
6/30/2020 9:24:43 AM
Sinovac Biotech Q1 Loss/Shr $0.07 Vs EPS $0.01 Last Year
6/11/2020 9:04:57 AM
Sinovac Biotech, Instituto Butantan Sign Development Collaboration
deal To Advance Clinical Trials Of CoronaVac
5/18/2020 8:35:23 AM
Sinovac Comments On SEC Findings Against Jiaqiang "Chiang" Li And 1Globe; Li And 1Globe Agree To Pay $290K Penalties
5/6/2020 10:37:33 AM
Sinovac : Study Shows Inactivated Vaccine Candidate Induced SARS-CoV-2-specific Neutralizing Antibodies In Mice, Rats